Dr. Kenneth Pettine Scholarship for Disabilities Opens 2027 Application Cycle for Undergraduate Students Nationwide
By Space Coast Daily // July 29, 2026
LOVELAND, Colo. – The Dr. Kenneth Pettine Scholarship for Disabilities today announced that applications are now being accepted for its 2027 scholarship program, offering a one-time award of $1,000 to an undergraduate student with a documented disability who demonstrates exceptional leadership, perseverance, and academic dedication.
Established by Dr. Kenneth Pettine—a board-certified orthopedic surgeon, founder of Paisley Laboratories, and a pioneer in regenerative medicine—the scholarship reflects his lifelong commitment to fostering innovation and supporting individuals who overcome adversity in pursuit of their educational goals. Dr. Kenneth Pettine, who earned his medical degree from the University of Colorado School of Medicine and a Master’s Degree in Orthopedic Biomechanics from the Mayo Graduate School of Medicine, has dedicated his career to improving patient outcomes through advanced research and medical technology. The scholarship program stands as a testament to Dr. Kenneth Pettine’s belief that determination and resilience should be recognized and rewarded.
The Dr. Kenneth Pettine Scholarship for Disabilities is open to undergraduate students currently enrolled at any accredited college or university across the United States. Eligible applicants must have a documented disability, maintain good academic standing, and demonstrate leadership qualities alongside a proven commitment to educational achievement.
As part of the application process, candidates are required to submit an original essay of 750 to 1,000 words responding to the following prompt: “How has living with a disability shaped your educational journey, personal growth, and future aspirations? Discuss the challenges you have overcome, the lessons you have learned, and how your experiences have influenced the impact you hope to make in your chosen field or community.” The review process prioritizes authenticity, clarity of vision, demonstrated perseverance, and the applicant’s potential to contribute positively to society.
Dr. Kenneth Pettine, whose career includes service as a principal investigator in numerous FDA clinical trials, contributions to extensive scientific literature, and the development of multiple patented medical innovations, established this scholarship to invest in the next generation of leaders who refuse to let physical or cognitive challenges define their limits. Through this initiative, Dr. Kenneth Pettine continues to champion the values of innovation and human resilience that have defined his professional journey.
Complete application packages must include the applicant’s full name, contact information, college or university name, current academic program and year of study, proof of undergraduate enrollment, the original essay response, and documentation verifying disability status if required. All materials must be submitted via email to apply@drkennethpettinescholarship.com no later than March 15, 2027. The scholarship recipient will be announced on April 15, 2027. Only complete applications received before the published deadline will be considered for review.
The Dr. Kenneth Pettine Scholarship for Disabilities represents a meaningful opportunity for undergraduate students across the nation who are determined to achieve their academic goals despite the obstacles associated with living with a disability. By providing financial support and academic recognition, the program aims to build a more inclusive academic landscape that celebrates diverse perspectives and determined career goals.
For more information about the Dr. Kenneth Pettine Scholarship for Disabilities, including full eligibility requirements and application instructions, please visit https://drkennethpettinescholarship.com/.
Media Contact:
Dr. Kenneth Pettine
Dr. Kenneth Pettine Scholarship for Disabilities
Website: https://drkennethpettinescholarship.com/
Email: apply@drkennethpettinescholarship.com













